Lifevantage Corporation
LFVN
Get informed when a big investor buys or sells
+ FollowMarket Cap$73.77M
Close$
$8.21
40.1% upside
Current Fair Value
40.1% upsideUndervalued by 40.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $73.77 Million |
|---|---|
| Enterprise Value | $68.72 Million |
| Dividend Yield | $0.19 (3.24%) |
| Earnings per Share | $0.4 |
| Beta | 0.71 |
| Outstanding Shares | 12,534,000 |
Return
| Return on Equity | 19.02% |
|---|---|
| Return on Assets | 10.28% |
| Return on Invested Capital | 8.82% |
Valuation & Multiples
| P/E Ratio | 14.65 |
|---|---|
| PEG | -42.2 |
| Price to Sales | 0.39 |
| Price to Book Ratio | 2.93 |
| Enterprise Value to Revenue | 0.36 |
| Enterprise Value to EBIT | 18.61 |
| Enterprise Value to Net Income | 10 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 3, 2026
EPS Estimate
$0.15
Average shareholder expectationRevenue Estimate
$44.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$0.03
Average shareholder expectationRevenue Estimate
$40.49 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 4.2713▲ 401.82% |
|---|---|
| Total Calls | 44,600▼ 57.40% |
| Total Puts | 190,500▲ 618.87% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 47.20%▼ 12.89% |
|---|---|
| Total Invested | $36.91M▲ 12.64% |
| Investors Holding | 95▼ 12.00% |
ESG Score
No data
About Lifevantage Corporation
CEO: Darren Jensen LifeVantage Corporation is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development and distribution of advanced nutraceutical dietary suppl...